Hepatitis B therapy ‘Virea’ sold for more than KRW 100 billion in 9 months
The collective sales of the Yuhan Corporation’s hepatitis B treatment ‘Viread’ by the last September were aggregated to exceed KRW 100 billion.
According to Yuhan Corporation, its 2016 third quarter’s collective sales were KRW 971.04 billion, increased by 17.6% compared to the same period of the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
